Circadian rhythm of melatonin in patients with colorectal carcinoma. 2002

Beata Kos-Kudla, and Zofia Ostrowska, and Andrzej Kozlowski, and Bogdan Marek, and Nelly Ciesielska-Kopacz, and Marek Kudla, and Dariusz Kajdaniuk, and Janusz Strzelczyk, and Pawel Staszewicz
Department of Pathophysiology and Endocrinology, Silesian Medical University, Zabrze, Poland. beatakos@ka.onet.pl

OBJECTIVE The aim of the study was pineal gland function assessment on the base of daily rhythm study and mean daily melatonin (MEL) concentrations in serum in patients with colorectal carcinoma. METHODS Studies were performed in 12 women at the age of 63.17+/-5.90 years and 21 men aged 58.95+/-11.32 years with large intestine adenocarcinoma. The control group consisted of 28 healthy volunteers at comparable age. During the circadian study blood samples for the measurement of melatonin (MEL) were collected every 4 hours during 12 h. MEL concentrations were assessed with the use of RIA methods. Statistical analysis of circadian rhythms of MEL was carried out with the use of cosinor method according to Halberg. RESULTS Existence of daily rhythm of MEL secretion was shown in all studied groups. A significant decrease of amplitude of rhythm and secretion of MEL at nocturnal hours in comparison with the control group was shown in the group of women with large intestine carcinoma. A significant decrease of mesor value and amplitude of MEL rhythm as a consequence of decrease of MEL secretion at nocturnal and morning hours was observed in the group of ill men. CONCLUSIONS Decrease in melatonin circadian rhythm amplitude as a consequence of its lowered nocturnal secretion occurred in all patients with colorectal carcinoma. Abnormalities in daily rhythm of melatonin secretion were more intensified in men with large intestine carcinoma, which leads to suppression of mean daily hormone concentration.

UI MeSH Term Description Entries
D008297 Male Males
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal

Related Publications

Beata Kos-Kudla, and Zofia Ostrowska, and Andrzej Kozlowski, and Bogdan Marek, and Nelly Ciesielska-Kopacz, and Marek Kudla, and Dariusz Kajdaniuk, and Janusz Strzelczyk, and Pawel Staszewicz
May 2008, Neuroscience letters,
Beata Kos-Kudla, and Zofia Ostrowska, and Andrzej Kozlowski, and Bogdan Marek, and Nelly Ciesielska-Kopacz, and Marek Kudla, and Dariusz Kajdaniuk, and Janusz Strzelczyk, and Pawel Staszewicz
November 2001, Revue neurologique,
Beata Kos-Kudla, and Zofia Ostrowska, and Andrzej Kozlowski, and Bogdan Marek, and Nelly Ciesielska-Kopacz, and Marek Kudla, and Dariusz Kajdaniuk, and Janusz Strzelczyk, and Pawel Staszewicz
October 1995, Psychopharmacology,
Beata Kos-Kudla, and Zofia Ostrowska, and Andrzej Kozlowski, and Bogdan Marek, and Nelly Ciesielska-Kopacz, and Marek Kudla, and Dariusz Kajdaniuk, and Janusz Strzelczyk, and Pawel Staszewicz
December 2004, Neuro endocrinology letters,
Beata Kos-Kudla, and Zofia Ostrowska, and Andrzej Kozlowski, and Bogdan Marek, and Nelly Ciesielska-Kopacz, and Marek Kudla, and Dariusz Kajdaniuk, and Janusz Strzelczyk, and Pawel Staszewicz
May 1987, Journal of the American Academy of Child and Adolescent Psychiatry,
Beata Kos-Kudla, and Zofia Ostrowska, and Andrzej Kozlowski, and Bogdan Marek, and Nelly Ciesielska-Kopacz, and Marek Kudla, and Dariusz Kajdaniuk, and Janusz Strzelczyk, and Pawel Staszewicz
April 2006, Acta neurologica Scandinavica,
Beata Kos-Kudla, and Zofia Ostrowska, and Andrzej Kozlowski, and Bogdan Marek, and Nelly Ciesielska-Kopacz, and Marek Kudla, and Dariusz Kajdaniuk, and Janusz Strzelczyk, and Pawel Staszewicz
January 2021, Endocrine, metabolic & immune disorders drug targets,
Beata Kos-Kudla, and Zofia Ostrowska, and Andrzej Kozlowski, and Bogdan Marek, and Nelly Ciesielska-Kopacz, and Marek Kudla, and Dariusz Kajdaniuk, and Janusz Strzelczyk, and Pawel Staszewicz
March 1997, Chronobiology international,
Beata Kos-Kudla, and Zofia Ostrowska, and Andrzej Kozlowski, and Bogdan Marek, and Nelly Ciesielska-Kopacz, and Marek Kudla, and Dariusz Kajdaniuk, and Janusz Strzelczyk, and Pawel Staszewicz
January 1998, Minerva medica,
Beata Kos-Kudla, and Zofia Ostrowska, and Andrzej Kozlowski, and Bogdan Marek, and Nelly Ciesielska-Kopacz, and Marek Kudla, and Dariusz Kajdaniuk, and Janusz Strzelczyk, and Pawel Staszewicz
January 2000, Seminars in clinical neuropsychiatry,
Copied contents to your clipboard!